|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Respiratory Syncytial Virus IgG ELISA | Amyloid Beta (1-42) ELISA Assay | Anti-Etanercept (Enbrel®) ELISA | Coxiella burnetii (Q-Fever) Phase 2 IgG ELISA Assay | DPP4 / CD26 ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79887 | 27711 | TM09007 | IB79834 | 27789 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Respiratory Syncytial Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Etanercept (Enbrel®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Coxiella burnetii phase 2 in the early stages of infection in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of DPP4 / CD26 in human serum, EDTA-plasma, urine, and CSF. For research use only, not for use in diagnostic procedures. |
| Detection Target | Total Estrogens | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | PSA (Free) | Helicobacter pylori IgG | Human T-Cadherin(30K, 130K) |
| Sample Type | Serum | Serum and plasma. | Serum | Serum, Blood Plasma | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 12.5 to 800 pg/mL | 0 / 3 - 1000 ng/mL | Inquire | 125 to 8000 pg/mL |
| Sensitivity | 4.4 pg/mL | 1 ng/mL | Inquire | > 96% | 0.005 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hours, 15 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |